Search
2 articles for “Posterior reversible encephalopathy syndrome”
-
Posterior Reversible Encephalopathy Syndrome Secondary to Management of Dimorphic Anemia by Repeated Blood Transfusions: A Case Report
Abstract: Posterior reversible encephalopathy syndrome, popularly known asPRES, is defined as a clinicoradiological syndrome which is characterized by symptoms such as headache, seizures, and altered consciousness and characterized by white matter vasogenic edema affecting the posterior occipital and parietal lobes of the brain .We report a 39-year-old woman who was treated by iron and blood transfusion for dimorphic anemia with a hemoglobin (Hb) level of 2 g/dl. Patient developed three episodes …
Published in Research and Reviews: A Journal of Medicine · Vol. 8, Issue 2, 2018 · pp. 6–8 Read article
-
Pharmacological Review On Enzalutamide
Abstract: A key therapeutic option in the treatment of prostate cancer, especially metastatic castration-resistant prostate cancer (mCRPC), is Enzalutamide, a second-generation anti androgen drug. Enzalutamide, discovered by Charles Sawyer and Michael Jung at the University of California, Los Angeles, was developed and Food and Drug Administration (FDA)-approved in 2012. Its therapeutic significance was further solidified with subsequent extensions in indications to encompass metastatic castration-sensitive prostate cancer and non-metastatic castration-resistant prostate cancer. …
Published in Trends in Drug Delivery · Vol. 11, Issue 2, 2024 · pp. 7–15 Read article